MicroRNA-103 promotes colorectal cancer by targeting tumor suppressor DICER and PTEN

International Journal of Molecular Sciences

Volumn 15, Issue 5, 2014, Pages 8458-8472

  Geng, Li ^a   Sun, Bing ^b   Gao, Bo ^a   Wang, Zheng ^a   Quan, Cheng ^a   Wei, Feng ^c   Fang, Xue Dong ^a  

^a THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^b Changchun Central Hospital   (China)

^c JILIN UNIVERSITY   (China)

Author keywords

Colorectal cancer; DICER; Migration; miR 103; Proliferation; PTEN

Indexed keywords

MICRORNA; MICRORNA 103; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; DEAD BOX PROTEIN; DICER1 PROTEIN, HUMAN; MESSENGER RNA; MIRN103 MICRORNA, HUMAN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PTEN PROTEIN, HUMAN; RIBONUCLEASE III;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL GROWTH ASSAY; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; COLORECTAL CANCER; CONTROLLED STUDY; DICER GENE; DNA SEQUENCE; DOWN REGULATION; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PTEN GENE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TUMOR VOLUME; UPREGULATION; WESTERN BLOTTING; 3' UNTRANSLATED REGION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL MOTION; CHEMISTRY; COLORECTAL TUMOR; FEMALE; GENETICS; HCT116 CELL LINE; HT 29 CELL LINE; METABOLISM; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PATHOLOGY; SEQUENCE ALIGNMENT; TUMOR CELL LINE; XENOGRAFT;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DEAD-BOX RNA HELICASES; DOWN-REGULATION; FEMALE; HCT116 CELLS; HT29 CELLS; HUMANS; MICE, NUDE; MICRORNAS; PTEN PHOSPHOHYDROLASE; RIBONUCLEASE III; RNA, MESSENGER; SEQUENCE ALIGNMENT; TRANSPLANTATION, HETEROLOGOUS; UP-REGULATION;

EID: 84900484192     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15058458     Document Type: Article

References (29)

1. Jemal, A.; Ward, E.; Hao, Y.; Thun, M. Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005, 294, 1255-1259.
2. Jafri, S.H.; Mills, G. Lifestyle modification in colorectal cancer patients: An integrative oncology approach. Future Oncol. 2013, 9, 207-218.
3. Bjerrum, J.T.; Nielsen, O.H.; Wang, Y.L.; Olsen, J. Technology insight: Metabonomics in gastroenterology-basic principles and potential clinical applications. Nat. Clin. Pr. Gastroenterol. Hepatol. 2008, 5, 332-343.
4. Astin, M.; Griffin, T.; Neal, R.D.; Rose, P.; Hamilton, W. The diagnostic value of symptoms for colorectal cancer in primary care: A systematic review. Br. J. Gen. Pr. 2011, 61, e231-e243.
5. Hristova, N.R.; Tagscherer, K.E.; Fassl, A.; Kopitz, J.; Roth, W. Notch1-dependent regulation of p27 determines cell fate in colorectal cancer. Int. J. Oncol. 2013, 43, 1967-1975.
6. Sung, M.K.; Yeon, J.Y.; Park, S.Y.; Park, J.H.; Choi, M.S. Obesity-induced metabolic stresses in breast and colon cancer. Ann. N. Y. Acad. Sci. 2011, 1229, 61-68.
7. Coghlin, C.; Murray, G.I. Progress in the identification of plasma biomarkers of colorectal cancer. Proteomics 2013, 13, 2227-2228.
8. Chen, K.; Rajewsky, N. The evolution of gene regulation by transcription factors and microRNAs. Nat. Rev. Genet. 2007, 8, 93-103.
9. Du, T.; Zamore, P.D. Beginning to understand microRNA function. Cell Res. 2007, 17, 661-663.
10. Cao, J.; Shen, Y.; Zhu, L.; Xu, Y.; Zhou, Y.; Wu, Z.; Li, Y.; Yan, X.; Zhu, X. miR-129-3p controls cilia assembly by regulating CP110 and actin dynamics. Nat. Cell Biol. 2012, 14, 697-706.
11. Nakasa, T.; Miyaki, S.; Okubo, A.; Hashimoto, M.; Nishida, K.; Ochi, M.; Asahara, H. Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum. 2008, 58, 1284-1292.
12. Chan, E.K.; Satoh, M.; Pauley, K.M. Contrast in aberrant microRNA expression in systemic lupus erythematosus and rheumatoid arthritis: Is microRNA-146 all we need? Arthritis Rheum. 2009, 60, 912-915.
13. Chen, C.Z. MicroRNAs as oncogenes and tumor suppressors. N. Engl. J. Med. 2005, 353, 1768-1771.
14. Hammond, S.M. MicroRNAs as oncogenes. Curr. Opin. Genet. Dev. 2006, 16, 4-9.
15. Zhang, B.; Chen, H.; Zhang, L.; Dakhova, O.; Zhang, Y.; Lewis, M.T.; Creighton, C.J.; Ittmann, M.M.; Xin, L. A dosage-dependent pleiotropic role of Dicer in prostate cancer growth and metastasis. Oncogene 2013, doi:10.1038/onc.2013.281.
16. Tamura, M.; Gu, J.; Matsumoto, K.; Aota, S.; Parsons, R.; Yamada, K.M. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 1998, 280, 1614-1617.
17. Maiques, O.; Santacana, M.; Valls, J.; Pallares, J.; Mirantes, C.; Gatius, S.; Garcia Dios, D.A.; Amant, F.; Pedersen, H.C.; Dolcet, X.; et al. Optimal protocol for PTEN immunostaining; role of analytical and preanalytical variables in PTEN staining in normal and neoplastic endometrial, breast, and prostatic tissues. Hum. Pathol. 2014, 45, 522-532.
18. Nyakern, M.; Cappellini, A.; Mantovani, I.; Martelli, A.M. Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated extrinsic cell death pathways. Mol. Cancer Ther. 2006, 5, 1559-1570.
19. Zhang, L.; Liu, X.; Jin, H.; Guo, X.; Xia, L.; Chen, Z.; Bai, M.; Liu, J.; Shang, X.; Wu, K.; et al. miR-206 inhibits gastric cancer proliferation in part by repressing cyclinD2. Cancer Lett. 2013, 332, 94-101.
20. Wang, X.; Yue, P.; Kim, Y.A.; Fu, H.; Khuri, F.R.; Sun, S.Y. Enhancing mammalian target of rapamycin (mTOR)-targeted cancer therapy by preventing mTOR/raptor inhibition-initiated, mTOR/rictor-independent Akt activation. Cancer Res. 2008, 68, 7409-7418.
21. Xu, C.X.; Li, Y.; Yue, P.; Owonikoko, T.K.; Ramalingam, S.S.; Khuri, F.R.; Sun, S.Y. The combination of RAD001 and NVP-BEZ235 exerts synergistic anticancer activity against non-small cell lung cancer in vitro and in vivo. PLoS One 2011, 6, e20899.
22. Xue, X.; Cao, A.T.; Cao, X.; Yao, S.; Carlson, E.D.; Soong, L.; Liu, C.G.; Liu, X.; Liu, Z.; Duck, L.W.; et al. Downregulation of microRNA-107 in intestinal CD11c, myeloid cells in response to microbiota and proinflammatory cytokines increases IL-23p19 expression. Eur. J. Immunol. 2014, 44, 673-682.
23. Bjaanaes, M.M.; Halvorsen, R.; Solberg, S.; Jorgensen, L.; Dragani, T.A.; Galvan, A.; Colombo, F.; Anderlini, M.; Pastorino, U.; Kure, E.; et al. Unique microRNA-profiles in EGFR-mutated lung adenocarcinomas. Int. J. Cancer 2014, doi:10.1002/ijc.28828.
24. Trajkovski, M.; Hausser, J.; Soutschek, J.; Bhat, B.; Akin, A.; Zavolan, M.; Heim, M.H.; Stoffel, M. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 2011, 474, 649-653.
25. Ellis, K.L.; Cameron, V.A.; Troughton, R.W.; Frampton, C.M.; Ellmers, L.J.; Richards, A.M. Circulating microRNAs as candidate markers to distinguish heart failure in breathless patients. Eur. J. Heart Fail. 2013, 15, 1138-1147.
26. Yu, D.; Zhou, H.; Xun, Q.; Xu, X.; Ling, J.; Hu, Y. MicroRNA-103 regulates the growth and invasion of endometrial cancer cells through the downregulation of tissue inhibitor of metalloproteinase 3. Oncol. Lett. 2012, 3, 1221-1226.
27. Chen, H.Y.; Lin, Y.M.; Chung, H.C.; Lang, Y.D.; Lin, C.J.; Huang, J.; Wang, W.C.; Lin, F.M.; Chen, Z.; Huang, H.D.; et al. miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4. Cancer Res. 2012, 72, 3631-3641.
28. Hong, Z.; Feng, Z.; Sai, Z.; Tao, S. PER3, a novel target of miR-103, plays a suppressive role in colorectal cancer in vitro. BMB Rep. 2014, pii, 2514.
29. Zhu, J.; Chen, L.; Zou, L.; Yang, P.; Wu, R.; Mao, Y.; Zhou, H.; Li, R.; Wang, K.; Wang, W.; et al. miR-20b,-21, and-130b inhibit PTEN expression resulting in B7-H1 over-expression in advanced colorectal cancer. Hum. Immunol. 2014, 75, 348-353.